Study guide
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy
Key Takeaways Explain This Topic AI
Surface reconstruction depends on lids, tears, sensation, inflammation and limbal support.
Partial/total and unilateral/bilateral LSCD determine donor and treatment options.
Holoclar has a defined adult burn-related EU indication and requires undamaged limbus for biopsy.
PTK treats superficial pathology but can change refraction and cannot correct every deep corneal problem.
Last updated: October 2026
Rebuild a viable surface before improving optics
Ocular-surface reconstruction aims to produce a stable epithelial barrier, adequate protection and a usable optical surface. A transparent donor cornea cannot remain clear if the recipient lacks epithelial support, lid protection or a suitable tear environment. Separate the immediate problem—such as a persistent defect or threatened perforation—from the long-term reason it recurs. Assess lids, lashes, blink, tear function, sensation, limbal status, inflammation and infection before choosing a reconstructive procedure.
Limbal stem-cell deficiency (LSCD) impairs replenishment of corneal epithelium. Conjunctival epithelium can extend over the cornea, producing irregular staining, recurrent defects, superficial vessels and loss of transparency. Chemical or thermal burns, chronic inflammatory disease, aniridia-related disease and some iatrogenic injuries are causes. LSCD can be partial or total and unilateral or bilateral; these distinctions change the available donor source and risk.
Confirm the dominant failure mechanism
Clinical signs include an irregular conjunctivalised surface, loss of normal limbal features and late fluorescein staining patterns, but a vascularised scar alone does not establish LSCD. Impression cytology or other specialist tests can support the diagnosis. Distinguish epithelial failure from stromal scarring and endothelial oedema: several mechanisms may coexist, but each requires a different intervention.
Control active inflammation and improve lid closure and tear support before elective transplantation where possible. A keratinised lid margin can abrade newly reconstructed epithelium, while severe aqueous deficiency compromises survival. Infection must be addressed. The patient’s ability to manage medicines and attend frequent follow-up is part of the surgical assessment, not merely an administrative consideration.
Limbal transplantation and cultured cells
In unilateral disease, autologous limbal tissue or cultured autologous cells may be available from a sufficiently healthy donor area. Harvesting carries a risk to the donor eye, so the amount and method matter. Simple limbal epithelial transplantation and cultivated approaches are distinct techniques; neither name implies an identical protocol or success rate. Bilateral disease may require allogeneic tissue or another epithelial strategy, with systemic immunosuppression and rejection issues considered where appropriate.
Holoclar is an EU-authorised cultured autologous corneal epithelial-cell product containing stem cells. Its indication is adult moderate-to-severe LSCD due to physical or chemical burns, including unilateral or bilateral disease, and it requires a small area of undamaged limbus for biopsy. It is not authorised as a universal treatment for every inherited or immune-mediated surface disorder. The current EMA product overview also records its transition from conditional to standard authorisation in 2024. Manufacturing and implantation require specialist facilities and patient-specific handling.
A successful epithelial reconstruction does not remove a deep stromal scar. A later optical graft may be considered once the surface is sufficiently stable. Sequence interventions around the biology rather than attempting all corrective procedures simply because the eye is already in theatre.
Protective closure and amniotic membrane
Tarsorrhaphy reduces exposure by partially or more extensively closing the lids. Temporary and longer-term techniques are selected according to the cause and expected recovery. Preserve the access needed for examination and treatment. It can be valuable in exposure or neurotrophic disease but must not conceal an unmonitored infection or progressing melt. Explain the trade-off between protection and temporary restriction of the visual field or appearance.
Amniotic membrane can support epithelial healing and modulate surface inflammation or scarring. It may be used as a graft, patch or multilayer construct, with different aims and orientation requirements. A membrane alone does not replace missing limbal stem cells in total LSCD. Persistent epithelial failure after membrane placement should trigger reassessment of the driver rather than automatic repetition indefinitely.
Phototherapeutic keratectomy
PTK uses excimer photoablation to remove superficial tissue and smooth an irregular cornea. It differs from refractive PRK because the main goal is therapeutic tissue removal, although refractive change can still occur. Suitable examples include selected superficial scars, recurrent erosion and superficial deposits. Depth of pathology, corneal thickness, surface regularity and healing potential determine suitability. An active infection or severe uncontrolled surface disorder is not corrected by simply ablating the opacity.
Procedure Primary goal Important limitation
Limbal epithelial restoration Re-establish a renewing corneal epithelium Does not remove every stromal or endothelial problem
Tarsorrhaphy Reduce exposure and improve protection Can restrict examination and vision if too extensive
Amniotic membrane Support healing and selected reconstruction Does not by itself supply a permanent stem-cell reservoir
PTK Remove/smooth superficial pathological tissue Can induce refractive change, haze or recurrence
Use masking techniques and ablation planning according to the lesion and platform rather than prescribing a universal number of micrometres. A smoother cornea may improve vision or comfort, but deeper opacity and irregular astigmatism can persist. After PTK, assess epithelial closure, infection, refractive change and recurrence.
A reconstructive decision
A burn survivor with total conjunctivalisation, severe dry eye and a stromal scar needs surface and lid rehabilitation before an optical graft is likely to succeed. A patient with a local superficial opacity and healthy sensation, tears and limbus may instead benefit from PTK. State which tissue function the proposed procedure restores and which limitations will remain; that explanation connects surgical choice to the examination rather than to a generic list of operations.
Sections you finish are checked off in the contents.
- Up Next
- PK, DALK and endothelial keratoplasty
- Continue learning